Author

Maryam Ghandali

Brown UniversityORCID 0000-0003-1651-7058Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2

Frequent Co-Authors

Benedito A. CarneiroiD· 2 shared Wafik S. El‐DeiryiD· 2 shared Andrew George· 1 shared Anna OchsneriD· 1 shared Clark C. CheniD· 1 shared Don Steven DizoniD· 1 shared Eric T. WongiD· 1 shared Kadir Mert Selvi· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Benedito A. CarneiroORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 12, 2026

Efficacy of Tumor Treating Fields (TTFields) in triple negative breast cancer cells and synergy with PARP inhibitor talazoparib

Maryam Ghandali, Praveen R. Srinivasan, Shengliang Zhang…·Wafik S. El‐Deiry

This study shows TTFields increase p21 expression and induce cell death in TNBC cells, with enhanced effects when combined with talazoparib.

DOI 10.64898/2026.10.09.757989

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintSep 24, 2026

ONC201 in combination with ATR inhibitor ceralasertib exhibits potent synergy in ovarian cancer cells

Maryam Ghandali, Kadir Mert Selvi, Kelsey E. Huntington…·Wafik S. El‐Deiry

This study shows that combining ONC201 with ATR inhibitor ceralasertib synergistically kills ovarian cancer cells by inducing apoptosis and reducing anti-apoptotic proteins.

DOI 10.64898/2026.09.23.753805

humanexperimental assay

𝕏 PostBluesky